Table 7: Factors associated with ART modification

Variable Modified Not modified OR (95% CI) P value
Gender

Male

Female


60 (33.9)

117 (66.1)


111 (36.5)

193 (63.5)


0.9 (0.6-1.3)

1.0


0.563
Age 36.9 (9.0) 37.1 (9.9 - 0.786
Initial WHO stage

I

II

III

IV


30 (16.9)

50 (28.2)

65 (36.7)

32 (18.1)


109 (35.9)

92 (30.3)

82 (27.0)

21 (6.9)


1.0

2.0 (1.2-3.4)

2.9 (1.7-4.8)

5.5 (2.8-11.0)




0.012

< 0.001

< 0.001
CD4+ at initiation of therapy 120 (50-206) 220 (117-314) - < 0.001
Initial CD4 cell counts

< 100

100-200

>200


79 (44.6)

51 (28.8)

47 (26.6)


63 (20.7)

74 (24.3)

167 (54.9)


4.5 (2.8-7.1)

2.4 (1.5-4.0)

1.0
< 0.001

< 0.001
Duration of initial regimen 26 (15-38) 16 (11-28) - < 0.001